Healthcare Equipment and Supplies
Company Overview of Acelity L.P. Inc.
Kinetic Concepts Inc. produces surgical healing and hospital patient-mobility equipment, including a tissue-repair therapy used in hospitals in the U.S. and worldwide for acute care and serious trauma. Its wound-care and tissue-repair system is used in pulmonary care, for post-cardiac-arrest complications in the intensive-care unit, and for other types of wound treatment including failed surgical closures, amputations, and serious pressure ulcers. The system works by using a vacuum-assisted closure technology. A second product is a line of hospital equipment that provides mobility to patients who cannot move because of pulmonary complications or due to obesity. Its bariatric-care products pr...
12930 West Interstate 10
San Antonio, TX 78249
Founded in 1976
Key Executives for Acelity L.P. Inc.
Chief Executive Officer, President and Director
Interim Chief Financial Officer
Senior Vice President of Operations, Quality & Regulatory
President of Developed Markets
Group President of Businesses & Innovation
Compensation as of Fiscal Year 2016.
Acelity L.P. Inc. Key Developments
Acelity Announces the Launch of iOn PROGRESS™ Care Network with Remote Therapy Monitoring
Oct 26 16
Acelity announced the launch of iOn PROGRESS™ Care Network with Remote Therapy Monitoring, a proprietary remote therapy monitoring system that delivers continuous at-home monitoring for patients prescribed negative pressure wound therapy (NPWT) in the home. The iOn PROGRESS™ technology enables timely feedback on patients’ use of NPWT, as well as increased clinician interaction to assist with patient compliance. iOn PROGRESS™ Remote Therapy Monitoring delivers the first continuous monitoring and ready intervention for patients receiving negative pressure wound therapy in the home. iOn PROGRESS™ Remote Therapy Monitoring works in conjunction with the ACTIV.A.C.™ Therapy System, which was specifically developed for patients treated in the home. The ACTIV.A.C.™ Therapy System’s lightweight, ergonomic design provides ease of use while the patented SENSAT.R.A.C.™ Technology, a real-time pressure feedback system designed to deliver and maintain the prescribed negative pressure, provides optimal healing outcomes. Remote therapy monitoring for wound care is particularly important for chronic wounds because compliance to prescribed therapy is a critical success factor for patients treated in the home. This new system is supported by the iOn PROGRESS™ Care Network, Acelity’s highly-trained nursing professionals who can interact with patients to drive proper utilization. This helps to ensure patient care is accurately tracked and proactive intervention is achieved when necessary.
Acelity L.P. Inc. Announces Availability of ALLODERM SELECT DUOTM Regenerative Tissue Matrix in the United States
Oct 19 16
Acelity L.P. Inc. announced that ALLODERM SELECT DUOTM Regenerative Tissue Matrix is now available in the United States. ALLODERM™ Regenerative Tissue Matrix is the biological tissue matrix for soft tissue reinforcement in breast reconstruction procedures, with more than 1.4 million implants to date. The new offering is a matched tissue matrix pair intended for patients undergoing bilateral breast reconstruction that provides uniform tissue characteristics, including same donor, shape and thickness, allowing for a more consistent product experience for both plastic surgeons and patients. ALLODERM SELECT DUO™ Regenerative Tissue Matrix delivers the regenerative qualities that surgeons have come to trust, while offering uniform tissue characteristics to better improve the bilateral breast reconstruction experience. Products in the ALLODERM™ Tissue Matrix portfolio are made from donated human dermis, processed to remove cells while preserving the essential biological components and structure of the dermal matrix to support tissue regeneration. Acelity uses proprietary processing that allows the matrices to support rapid revascularization, cell repopulation and white cell migration, offering surgeons a natural solution for soft tissue support where weakness exists. ALLODERM SELECT DUO™ is available in the updated thicknesses and improved packaging. In addition to ALLODERM SELECT™ and ALLODERM SELECT DUO™ Tissue Matrices, Acelity has initiated a limited launch of the ARTIA™ Reconstructive Tissue Matrix, a new porcine acellular dermal matrix, in the U.S. and full launch in Europe.
Acelity L.P. Inc. Announces Management Changes
Sep 12 16
Acelity L.P. Inc. announced that Tom Casey, Executive Vice President and Chief Financial Officer for Acelity, has resigned from his role at Acelity, effective September 16 in order to accept another employment opportunity. Todd Wyatt, Vice President, Global Corporate Finance, will serve as interim CFO while Acelity conducts the formal process of identifying Casey’s successor. Wyatt joined the company in 2004 and has previously served as Vice President, Global Corporate Finance, overseeing the financial operations for Acelity.
Similar Private Companies By Industry
Recent Private Companies Transactions